News - Legal, Oncology


Current filters:


Popular Filters

1 to 25 of 36 results

Lilly's Alimta patent upheld through 2022

Lilly's Alimta patent upheld through 2022


US pharma major Eli Lilly says that the US District Court for the Southern District of Indiana has ruled…

AlimtaEli LillyLegalNorth AmericaOncologyPatentsPharmaceuticalTeva Pharmaceutical IndustriesUSA

Whistleblower law suit against Celgene unsealed

Whistleblower law suit against Celgene unsealed


A US federal court yesterday unsealed a whistleblower/false claims law suit brought against US biotech…

BiotechnologyCelgeneLegalMarkets & MarketingNorth AmericaOncologyRevlimidThalomidUSA

PDL BioPharma settles litigation with Genentech and Roche


US drugmaker PDL BioPharma has entered into an agreement with Genentech and its parent, Swiss drug major…

BiotechnologyFinancialGenentechLegalOncologyOphthalmicsPDL BioPharmaRoche

Brazil Court annuls marketing approval for sub-standard Taxotere biosimilar

Brazil Court annuls marketing approval for sub-standard Taxotere biosimilar


The Superior Court of Justice in Brazil recently annulled marketing approval for a sub-standard biosimilar…

BiosimilarsDoxelibGenericsLegalLibra LaboratoryOncologyRegulationSanofiSouth AmericaTaxotere

New Brazilian law favors home treatment of cancer patients


Starting next year, supplemental and private health insurance companies in Brazil will be required to…

FinancialHealthcareLegalOncologySouth America

Another blow for Pharma, as India revokes Tykerb patent


UK pharma giant GlaxoSmithKline (LSE: GSK) has confirmed that India's Intellectual Property Appellate…


Mylan enters Tarceva settlement agreement


US generics firm Mylan (Nasdaq: MYL) has entered into a settlement agreement with OSI Pharmaceuticals,…

GenentechGenericsLegalMylan LaboratoriesNorth AmericaOncologyOSI PharmaceuticalsPatentsPfizerTarceva

US Court denies re-hearing of Arzerra patent case


Danish drugmaker Genmab (OMX: GEN) says that the US Court of Appeals for the Federal Circuit has declined…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceutical

Japan Supreme Court absolves AstraZeneca over deaths associated with Iressa


The Japanese Supreme Court has upheld high court rulings that the Japanese unit of Anglo-Swedish drug…


Cyclacel sells four disputed romidepsin-related patents to Celgene


USA based Cyclacel Pharmaceuticals (Nasdaq: CYCC) says that it has entered into a definitive agreement…

BiotechnologyCelgeneCyclacel PharmaceuticalsLegalOncologyPatentsromidepsin

India's Supreme Court denies Novartis Glivec patent appeal


In a landmark decision issued on Monday (April 1) by the Indian Supreme Court has denied Swiss drug major…


Cipla prevails in Sutent patent dispute with Pfizer; puts hold on Cipla Medpro deal


The Indian patent office has again ruled in favor of domestic drugmaker Cipla (BSE: 500087), reinstating…

Asia-PacificCiplaCipla MedproGenericsLegalMergers & AcquisitionsOncologyPatentsPfizerRest of the WorldSutent

MSF update on Novartis versus India, Supreme Court case


Humanitarian health organization Medecins Sans Frontieres (MSF) says it continues to follow progress…


Another negative Indian patent ruling, this time for Pfizer's Sutent


In yet another setback for research-based pharmaceutical companies, last week the Indian patent office…

Asia-PacificCiplaGenericsLegalNatco PharmaOncologyPatentsPfizerPharmaceuticalSutent

India's IPAB rejects Bayer's "stay petition" regarding Nexavar


Over the weekend, the Intellectual Property Appellate Board (IPAB) of Chennai, India, has dismissed the…

Asia-PacificBayerGenericsLegalNatco PharmaNexavarOncologyPatentsPharmaceutical

Pfizer links with SFJ Pharma for dacomitinib trial; settles with Mylan


SFJ Pharmaceuticals Group, a global drug development group of companies which provides a unique co-development…

dacomitinibDetrol LAGastro-intestinalsGenericsLegalMylan LaboratoriesNorth AmericaOncologyPatentsPfizerPharmaceuticalResearchSFJ Pharmaceuticals

Bayer attempts to block generic Nexavar in India again slammed by MSF


German drug major Bayer (BAYN: DE) yesterday headed to India's Intellectual Property Appellate Board…


Mixed news on Lilly's Alzheimer's drug solanezumab; Alimta patent upheld


US drug major Eli Lilly (NYSE: LLY) revealed last Friday that the primary endpoints, both cognitive and…

AlimtaEli LillyLegalNeurologicalNorth AmericaOncologyPatentsPharmaceuticalResearchsolanezumabTeva Pharmaceutical Industries

1 to 25 of 36 results

Back to top